BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 5, 2017
View Archived Issues
Bristol-Myers Squibb offers pipeline update of first quarter 2017
Read More
AstraZeneca updates regulatory and clinical progress of first quarter 2017
Read More
Vivet Therapeutics closes series A financing round
Read More
Lundbeck describes brain-penetrant PDE1 inhibitors for cognitive disorders
Read More
NIH grant supports Spero's preclinical development of SPR-720 for TB
Read More
FDA awards new designations to three Sangamo programs
Read More
Saniona participates in formation of Scandion Oncology
Read More
OncoMed initiates phase Ia study of OMP-313M32 in advanced solid tumors
Read More
FLX-787 demonstrates clinical benefit for treating nocturnal leg cramping
Read More
Celsion reports new data from OVATION study of GEN-1 in ovarian cancer
Read More
Polymorphism in TDP1 associated with poor survival in SCLC patients
Read More
Zafgen reports phase I topline data on ZGN-1061
Read More
ImMAGE Biotherapeutics begins repeat toxicology study for IMT-001
Read More
Galapagos identifies IRAK-4 inhibitors
Read More
Rhythm advances setmelanotide program into phase III for pro-opiomelanocortin deficiency obesity
Read More
Otsuka Pharmaceutical patents MAPK3 and MAPK1 inhibitors
Read More
Cardioxyl Pharmaceuticals divulges nitroxyl donors
Read More
ISIS-581088/AZD-5363 studies target the androgen receptor and AKT kinase in prostate cancer
Read More
Array BioPharma discovers FGFR tyrosine kinases inhibitors
Read More
Aplidin granted orphan drug designation in Switzerland for multiple myeloma
Read More
Shanghai Institute Materia Medica and Sunnylife Pharma patent BTK inhibitors
Read More
ADC Therapeutics enrolling patients in phase I trial of ADCT-502
Read More
Dauntless Pharmaceuticals reports promising phase I results for intranasal octreotide acetate
Read More
MDxHealth and Maastricht University expand research collaboration
Read More
Commense signs licensing agreement with UBC for microbiome-based therapy to prevent asthma
Read More
Compound shows promise in vivo for heart failure therapy
Read More